Prediction of personalized drugs based on genetic variations provided by DNA sequencing technologies

다국어 초록 (Multilingual Abstract)

Recent reports of death and illness caused by adverse drug reactions have boosted rational drug design research. It has been shown through sequencing of the entire human genome that human genetic variations play a key role in adverse reactions to drugs as well as in differences in the effectiveness of drug treatments. The advent of high-throughput DNA sequencing technologies with bioinformatics of system biology have allowed the easy identification of genetic variations and all other pharmacogenetic variants in a single assay, thus permitting truly personalized drug treatment. This would be particularly valuable for many patients with chronic diseases who must take many medications concurrently. In this review, we have focused on pharmacogenomics for the prediction of variable drug responses between individuals with relevant genetic variations through new DNA sequencing technologies and provided directions for personalized drug therapy in the future.

참고문헌 (Reference)

1 Guillem VM, "XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia" 85 : 482-486, 2010

2 Bentley DR, "Whole-genome re-sequencing" 16 : 545-552, 2006

3 Gunderson KL, "Whole-genome genotyping of haplotype tag single nucleotide polymorphisms" 7 : 641-648, 2006

4 Kruglyak L, "Variation is the spice of life" 27 : 234-236, 2001

5 Yasuda K, "Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus" 40 : 1092-1097, 2008

6 Glurich I, "Understanding the pharmacogenetic approach to warfarin dosing" 15 : 239-248, 2010

7 Gudmundsson J, "Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes" 39 : 977-983, 2007

8 Bennett ST, "Toward the 1,000 dollars human genome" 6 : 373-382, 2005

9 Wolinsky H, "The thousand-dollar genome. Genetic brinkmanship or personalized medicine" 8 : 900-903, 2007

10 Tazi J, "The spliceosome: a novel multi-faceted target for therapy" 30 : 469-478, 2005

11 아밋멜러, "The potential and challenges of nanopore sequencing" 26 (26): 1146-1153, 200810

12 Mardis ER, "The impact of next-generation sequencing technology on genetics" 24 : 133-141, 2008

13 Wang J, "The diploid genome sequence of an Asian individual" 456 : 60-65, 2008

14 Lesko LJ, "The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics" 84 : 301-303, 2008

15 Collins FS, "The Human Genome Project: lessons from large-scale biology" 300 : 286-290, 2003

16 Chen X, "The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population" 78 : 249-259, 2005

17 Halling J, "The CYP2D6 polymorphism in relation to the metabolism of amitriptyline and nortriptyline in the Faroese population" 65 : 134-138, 2008

18 McNeish JD, "Stem cells as screening tools in drug discovery" 7 : 515-520, 2007

19 Weinstein JN, "Spotlight on molecular profiling: "Integromic" analysis of the NCI-60 cancer cell lines" 5 : 2601-2605, 2006

20 Dekker C, "Solid-state nanopores" 2 : 209-215, 2007

21 Iqbal SM, "Solid-state nanopore channels with DNA selectivity" 2 : 243-248, 2007

22 Harris TD, "Single-molecule DNA sequencing of a viral genome" 320 : 106-109, 2008

23 Chou KC, "Signal-CF: a subsite-coupled and window-fusing approach for predicting signal peptides" 357 : 633-640, 2007

24 Shen HB, "Signal-3L: A 3-layer approach for predicting signal peptides" 363 : 297-303, 2007

25 Fu DJ, "Sequencing exons 5 to 8 of the p53 gene by MALDI-TOF mass spectrometry" 16 : 381-384, 1998

26 Braslavsky I, "Sequence information can be obtained from single DNA molecules" 100 : 3960-3964, 2003

27 Perry HM, Jr, "Relationship of acetyl transferase activity to antinuclear antibodies and toxic symptoms in hypertensive patients treated with hydralazine" 76 : 114-125, 1970

28 Ronaghi M, "Real-time DNA sequencing using detection of pyrophosphate release" 242 : 84-89, 1996

29 Eid J, "Real-time DNA sequencing from single polymerase molecules" 323 : 133-138, 2009

30 Zwolak M, "Quantized ionic conductance in nanopores" 103 : 128102-, 2009

31 Chou KC, "ProtIdent: a web server for identifying proteases and their types by fusing functional domain and sequential evolution information" 376 : 321-325, 2008

32 Jurica MS, "Pre-mRNA splicing: awash in a sea of proteins" 12 : 5-14, 2003

33 Reidenberg MM, "Polymorphic acetylation procainamide in man" 17 : 722-730, 1975

34 Choo EF, "Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes" 28 : 655-660, 2000

35 Wang L, "Pharmacogenomics: candidate gene identification, functional validation and mechanisms" 17 : 174-179, 2008

36 Mango R, "Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy" 6 : 2565-2576, 2005

37 Lindpaintner K, "Pharmacogenetics and pharmacogenomics in drug discovery and development: an overview" 41 : 398-410, 2003

38 McVean G, "Perspectives on human genetic variation from the HapMap Project" 1 : 54-, 2005

39 Xu M, "Perspectives and challenges of emerging single-molecule DNA sequencing technologies" 5 : 2638-2649, 2009

40 Lundquist PM, "Parallel confocal detection of single molecules in real time" 33 : 1026-1026, 2008

41 Korbel JO, "Paired-end mapping reveals extensive structural variation in the human genome" 318 : 420-426, 2007

42 Gardy JL, "PSORT-B: Improving protein subcellular localization prediction for Gram-negative bacteria" 31 : 3613-3617, 2003

43 Lennard MS, "Oxidation phenotype--a major determinant of metoprolol metabolism and response" 307 : 1558-1560, 1982

44 Libioulle C, "Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4" 3 : 58-, 2007

45 Conti E, "Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species" 17 : 316-325, 2005

46 Levy SF, "Network hubs buffer environmental variation in Saccharomyces cerevisiae" 6 : 264-, 2008

47 Weber WW, "N-acetylation pharmacogenetics" 37 : 25-79, 1985

48 Clark LN, "Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor" 16 : 132-135, 2010

49 Rost S, "Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2" 427 : 537-541, 2004

50 Ruan Y, "Multiplex parallel pair-end-ditag sequencing approaches in system biology. Wiley Interdiscip" 2 : 224-234, 2010

51 Ni LN, "Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia" 28 : 265-269, 2011

52 Chou KC, "MemType-2L: a web server for predicting membrane proteins and their types by incorporating evolution information through Pse-PSSM" 360 : 339-345, 2007

53 Budnitz DS, "Medication use leading to emergency department visits for adverse drug events in older adults" 147 : 755-765, 2007

54 Tucker T, "Massively parallel sequencing: the next big thing in genetic medicine" 85 : 142-154, 2009

55 Edwards JR, "Mass-spectrometry DNA sequencing" 573 : 3-12, 2005

56 Kidd JM, "Mapping and sequencing of structural variation from eight human genomes" 453 : 56-64, 2008

57 Ameyaw MM, "MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity" 11 : 217-221, 2001

58 Lowe CE, "Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes" 39 : 1074-1082, 2007

59 ten Bosch JR, "Keeping up with the next generation: massively parallel sequencing in clinical diagnostics" 10 : 484-492, 2008

60 Johansson I, "Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine" 90 : 11825-11829, 1993

61 Molanaei H, "Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease" 66 : 269-273, 2010

62 Stout SM, "Influence of Metoprolol Dosage Release Formulation on the Pharmacokinetic Drug Interaction With Paroxetine" 51 : 389-396, 2011

63 Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors" 126 : 663-676, 2006

64 Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors" 131 : 861-872, 2007

65 Gerloff T, "Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distribution. Naunyn Schmiedebergs" 369 : 69-77, 2004

66 Kalow W, "Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research" 8 : 283-289, 1998

67 Laustriat D, "Human pluripotent stem cells in drug discovery and predictive toxicology" 38 : 1051-1057, 2010

68 Pearson TA, "How to interpret a genome-wide association study" 299 : 1335-1344, 2008

69 Maraganore DM, "High-resolution whole-genome association study of Parkinson disease" 77 : 685-693, 2005

70 O'Reilly RA, "Hereditary Transmission of Exceptional Resistance to Coumarin Anticoagulant Drugs. The First Reported Kindred" 271 : 809-815, 1964

71 Shen HB, "HIVcleave: a web-server for predicting human immunodeficiency virus protease cleavage sites in proteins" 375 : 388-390, 2008

72 Kim VN, "Genomics of microRNA" 22 : 165-173, 2006

73 Ginsburg GS, "Genomic and personalized medicine: foundations and applications" 154 : 277-287, 2009

74 Need AC, "Genome-wide tagging for everyone" 38 : 1227-1228, 2006

75 Easton DF, "Genome-wide association study identifies novel breast cancer susceptibility loci" 447 : 1087-1093, 2007

76 Rioux JD, "Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis" 39 : 596-604, 2007

77 Scuteri A, "Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits" 3 : 115-, 2007

78 Moffatt MF, "Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma" 448 : 470-473, 2007

79 Nakajima M, "Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans" 125 : 803-808, 1999

80 Service RF, "Gene sequencing. The race for the $1000 genome" 311 : 1544-1546, 2006

81 Hoffmeyer S, "Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo" 97 : 3473-3478, 2000

82 Fretland AJ, "Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms" 11 : 207-215, 2001

83 Ozaki K, "Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction" 32 : 650-654, 2002

84 Jones M, "Francis Collins Addresses State of Personalized Medicine. GenomeWeb [online]"

85 Druker BJ, "Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia" 355 : 2408-2417, 2006

86 Shen HB, "EzyPred: a top-down approach for predicting enzyme functional classes and subclasses" 364 : 53-59, 2007

87 McNeish J, "Embryonic stem cells in drug discovery" 3 : 70-80, 2004

88 Thomson JA, "Embryonic stem cell lines derived from human blastocysts" 282 : 1145-1147, 1998

89 Hay DC, "Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo" 26 : 894-902, 2008

90 Rieder MJ, "Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose" 352 : 2285-2293, 2005

91 Sanger F, "DNA sequencing with chain-terminating inhibitors" 74 : 5463-5467, 1977

92 Edwards JR, "DNA sequencing using biotinylated dideoxynucleotides and mass spectrometry" 29 : 104-104, 2001

93 Roskey MT, "DNA sequencing by delayed extraction-matrix-assisted laser desorption/ionization time of flight mass spectrometry" 93 : 4724-4729, 1996

94 Mega JL, "Cytochrome p-450 polymorphisms and response to clopidogrel" 360 : 354-362, 2009

95 Zanger UM, "Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch" 369 : 23-37, 2004

96 Myers RH, "Considerations for genomewide association studies in Parkinson disease" 78 : 1081-1082, 2006

97 Klein RJ, "Complement factor H polymorphism in age-related macular degeneration" 308 : 385-389, 2005

98 Cornelis MC, "Coffee, CYP1A2 genotype, and risk of myocardial infarction" 295 : 1135-1141, 2006

99 Kiyohara C, "Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population" 18 : 630-638, 2009

100 Kasianowicz JJ, "Characterization of individual polynucleotide molecules using a membrane channel" 93 : 13770-13773, 1996

101 Thiebaut F, "Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues" 84 : 7735-7738, 1987

102 Chou KC, "Cell-PLoc: a package of Web servers for predicting subcellular localization of proteins in various organisms" 3 : 153-162, 2008

103 Pereira NL, "Cardiovascular pharmacogenomics and individualized drug therapy" 6 : 632-638, 2009

104 Fedurco M, "BTA, a novel reagent for DNA attachment on glass and efficient generation of solid-phase amplified DNA colonies" 34 : 22-, 2006

105 Aithal GP, "Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications" 353 : 717-719, 1999

106 Guo J, "An integrated system for DNA sequencing by synthesis using novel nucleotide analogues" 43 : 551-563, 2010

107 Nebert DW, "Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead" 500 : 267-280, 2004

108 Bentley DR, "Accurate whole human genome sequencing using reversible terminator chemistry" 456 : 53-59, 2008

109 Drmanac S, "Accurate sequencing by hybridization for DNA diagnostics and individual genomics" 16 : 54-58, 1998

110 Shendure J, "Accurate multiplex polony sequencing of an evolved bacterial genome" 309 : 1728-1732, 2005

111 Conrad DF, "A worldwide survey of haplotype variation and linkage disequilibrium in the human genome" 38 : 1251-1260, 2006

112 Fellay J, "A whole-genome association study of major determinants for host control of HIV-1" 317 : 944-947, 2007

113 Collins FS, "A vision for the future of genomics research" 422 : 835-847, 2003

114 Frazer KA, "A second generation human haplotype map of over 3.1 million SNPs" 449 : 851-861, 2007

115 Court MH, "A pharmacogenomics primer" 47 : 1087-1103, 2007

116 Maxam AM, "A new method for sequencing DNA" 74 : 560-564, 1977

117 Sladek R, "A genome-wide association study identifies novel risk loci for type 2 diabetes" 445 : 881-885, 2007

118 Hunter DJ, "A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer" 39 : 870-874, 2007

119 Hakonarson H, "A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene" 448 : 591-594, 2007

120 Duerr RH, "A genome-wide association study identifies IL23R as an inflammatory bowel disease gene" 314 : 1461-1463, 2006

121 van Heel DA, "A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21" 39 : 827-829, 2007

122 Buch S, "A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease" 39 : 995-999, 2007

123 Andersson U, "A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk" 49 : 767-775, 2010

124 Helgadottir A, "A common variant on chromosome 9p21 affects the risk of myocardial infarction" 316 : 1491-1493, 2007

125 Frayling TM, "A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity" 316 : 889-894, 2007

126 Cox A, "A common coding variant in CASP8 is associated with breast cancer risk" 39 : 352-358, 2007

127 McPherson R, "A common allele on chromosome 9 associated with coronary heart disease" 316 : 1488-1491, 2007